Morgan Stanley’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-163,299
| Closed | -$483K | – | 8188 |
|
|
2022
Q3 | $483K | Sell |
163,299
-19,300
| -11% | -$73.1K | ﹤0.01% | 5285 |
|
|
2022
Q2 | $822K | Sell |
182,599
-819
| -0.4% | -$4.36K | ﹤0.01% | 5147 |
|
|
2022
Q1 | $1.07M | Sell |
183,418
-4,881
| -3% | -$27.2K | ﹤0.01% | 4945 |
|
|
2021
Q4 | $1.12M | Sell |
188,299
-5,830
| -3% | -$37.3K | ﹤0.01% | 4990 |
|
|
2021
Q3 | $1.32M | Buy |
194,129
+12,330
| +7% | +$108K | ﹤0.01% | 4871 |
|
|
2021
Q2 | $1.56M | Buy |
181,799
+2,099
| +1% | +$15.6K | ﹤0.01% | 4813 |
|
|
2021
Q1 | $1.23M | Sell |
179,700
-5,545
| -3% | -$40.3K | ﹤0.01% | 4597 |
|
|
2020
Q4 | $1.3M | Buy |
185,245
+19,005
| +11% | +$128K | ﹤0.01% | 4496 |
|
|
2020
Q3 | $1.03M | Buy |
166,240
+55,741
| +50% | +$353K | ﹤0.01% | 4200 |
|
|
2020
Q2 | $679K | Buy |
110,499
+62,605
| +131% | +$399K | ﹤0.01% | 4437 |
|
|
2020
Q1 | $269K | Buy |
47,894
+11,795
| +33% | +$74.6K | ﹤0.01% | 4740 |
|
|
2019
Q4 | $234K | Buy |
36,099
+3,770
| +12% | +$24.5K | ﹤0.01% | 5353 |
|
|
2019
Q3 | $231K | Buy |
32,329
+858
| +3% | +$5.71K | ﹤0.01% | 5062 |
|
|
2019
Q2 | $207K | Buy |
31,471
+1,215
| +4% | +$9.07K | ﹤0.01% | 5009 |
|
|
2019
Q1 | $252K | Buy |
30,256
+3,307
| +12% | +$27.8K | ﹤0.01% | 4946 |
|
|
2018
Q4 | $147K | Buy |
26,949
+4,186
| +18% | +$42.2K | ﹤0.01% | 5408 |
|
|
2018
Q3 | $363K | Buy |
22,763
+3,772
| +20% | +$73.9K | ﹤0.01% | 5164 |
|
|
2018
Q2 | $361K | Buy |
18,991
+8,832
| +87% | +$152K | ﹤0.01% | 5286 |
|
|
2018
Q1 | $154K | Buy |
10,159
+4,163
| +69% | +$101K | ﹤0.01% | 5573 |
|
|
2017
Q4 | $155K | Buy |
5,996
+3,353
| +127% | +$117K | ﹤0.01% | 5501 |
|
|
2017
Q3 | $112K | Buy |
2,643
+774
| +41% | +$107K | ﹤0.01% | 5543 |
|
|
2017
Q2 | $266K | Sell |
1,869
-2,887
| -61% | -$402K | ﹤0.01% | 5178 |
|
|
2017
Q1 | $716K | Buy |
4,756
+1,735
| +57% | +$327K | ﹤0.01% | 4616 |
|
|
2016
Q4 | $318K | Buy |
3,021
+1,438
| +91% | +$189K | ﹤0.01% | 5161 |
|
|
2016
Q3 | $233K | Buy |
1,583
+875
| +124% | +$123K | ﹤0.01% | 4948 |
|
|
2016
Q2 | $90K | Sell |
708
-77
| -10% | -$10.4K | ﹤0.01% | 5288 |
|
|
2016
Q1 | $93K | Sell |
785
-2,631
| -77% | -$295K | ﹤0.01% | 5349 |
|
|
2015
Q4 | $455K | Buy |
3,416
+75
| +2% | +$12K | ﹤0.01% | 4608 |
|
|
2015
Q3 | $551K | Buy |
3,341
+94
| +3% | +$19.8K | ﹤0.01% | 4541 |
|
|
2015
Q2 | $864K | Buy |
3,247
+12
| +0.4% | +$2.87K | ﹤0.01% | 4319 |
|
|
2015
Q1 | $641K | Buy |
3,235
+1,703
| +111% | +$276K | ﹤0.01% | 4476 |
|
|
2014
Q4 | $223K | Buy |
+1,532
| New | +$221K | ﹤0.01% | 5183 |
|
Other funds holding FWP
Morgan Stanley's FWP Position: Q4 2022 in Review
Morgan Stanley sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q4 2022, closing a stake of 163,299 shares — an estimated $483K sold.
Morgan Stanley first reported a position in FWP in Q4 2014 and held it in 32 quarters. The position peaked at $1.56M in Q2 2021. 2 funds tracked by Wall St. Rank hold FWP as of Q4 2022.
- Morgan Stanley reported no remaining Forward Pharma A/S American Depositary Shares position as of Q4 2022 after selling out during the quarter.
- Morgan Stanley sold 163,299 Forward Pharma A/S American Depositary Shares shares in Q4 2022, an estimated $483K.
- Morgan Stanley first reported a position in Forward Pharma A/S American Depositary Shares in Q4 2014 and held it in 32 quarters.
- Morgan Stanley's Forward Pharma A/S American Depositary Shares position peaked at $1.56M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q4 2022.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.